🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The study is being conducted to evaluate the efficacy and safety of HRS-808...
Status
Recruiting
Location
Chinese PLA General Hospital Fifth Medical Center
Start Date
2026-05-05
Trial ID
NCT07354022
Treatments Being Tested
The study is being conducted to evaluate the safety and tolerability of HRS...
Status
Recruiting
Location
Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
Start Date
2023-02-07
Trial ID
NCT05628870
Treatments Being Tested
This study was to evaluate the safety and efficacy of dalcilide tablets in ...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2023-10
Trial ID
NCT06099990
This is a multicenter, open phase Ib/II clinical study, which is divided in...
Status
Recruiting
Location
Chinese PLA General Hospital Fifth Medical Center
Start Date
2023-12-20
Trial ID
NCT06167694
Treatments Being Tested
The purpose of this study is to observe and evaluate the efficacy and safet...
Status
Recruiting
Location
Department of GI Oncology, Peking University Cancer Hospital,
Start Date
2024-11-01
Trial ID
NCT06684600
Treatments Being Tested
Based on different HR status, we explored the efficacy and safety of Pyroti...
Status
Unknown
Location
Henan Cancer Hospital
Start Date
2022-05-20
Trial ID
NCT05328440
Treatments Being Tested
This study aims to evaluate the safety, tolerability, PK and preliminary an...
Status
Unknown
Location
Multiple Locations
Start Date
2023-04
Trial ID
NCT05792410
This study is a prospective, exploratory clinical study design, and plans t...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-09-23
Trial ID
NCT07189884
Treatments Being Tested
This single-center, open-label Phase II trial aims to evaluate the efficacy...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-09-01
Trial ID
NCT07778732
Treatments Being Tested